Baird Isn't Changing Its Outlook On Amgen

By: via Benzinga
Baird previewed Amgen, Inc. (NASDAQ: AMGN)'s upcoming 2Q16 earnings scheduled to be released on July 27. In the report published ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.